Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 10, Pages 1584
Publisher
MDPI AG
Online
2019-10-17
DOI
10.3390/cancers11101584
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors
- (2019) Dimitrios Nasioudis et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase II study of avelumab in multiple relapsed/refractory testicular germ cell cancer.
- (2019) Michal Mego et al. JOURNAL OF CLINICAL ONCOLOGY
- Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989–2015
- (2019) O.L. van der Hel et al. EUROPEAN JOURNAL OF CANCER
- Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2018) I Ray-Coquard et al. ANNALS OF ONCOLOGY
- Systemic immune-inflammation index in germ-cell tumours
- (2018) Michal Chovanec et al. BRITISH JOURNAL OF CANCER
- The role of staging and adjuvant chemotherapy in stage I Malignant ovarian germ cell tumors (MOGTs): the MITO-9 study
- (2016) G. Mangili et al. ANNALS OF ONCOLOGY
- Investigational targeted therapies for the treatment of testicular germ cell tumors
- (2016) Christoph Oing et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Chemotherapy in ovarian germ cell tumors: A systematic review
- (2016) Christine G. Simone et al. GYNECOLOGIC ONCOLOGY
- Phase II study of everolimus in refractory testicular germ cell tumors
- (2016) Michal Mego et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
- (2016) Costantine Albany et al. Oncotarget
- Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
- (2015) Z. Cierna et al. ANNALS OF ONCOLOGY
- Frequent PD-L1 expression in testicular germ cell tumors
- (2015) C D Fankhauser et al. BRITISH JOURNAL OF CANCER
- Development of a risk stratification system to guide treatment for female germ cell tumors
- (2015) Jane L. Meisel et al. GYNECOLOGIC ONCOLOGY
- High-Dose Chemotherapy for Recurrent Ovarian Germ Cell Tumors
- (2015) Natraj Reddy Ammakkanavar et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors
- (2014) David J. Vaughn et al. CANCER
- Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors
- (2014) Jubilee Brown et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Cisplatin Induces Resistance by Triggering Differentiation of Testicular Embryonal Carcinoma Cells
- (2014) Paolo B. Abada et al. PLoS One
- Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4
- (2013) M. Gutekunst et al. CANCER RESEARCH
- The PDGFRβ–AKT Pathway Contributes to CDDP-Acquired Resistance in Testicular Germ Cell Tumors
- (2013) M. Juliachs et al. CLINICAL CANCER RESEARCH
- Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer
- (2013) R. Koster et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- PARP expression in germ cell tumours
- (2013) Michal Mego et al. JOURNAL OF CLINICAL PATHOLOGY
- Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
- (2012) J. Beyer et al. ANNALS OF ONCOLOGY
- Malignant ovarian germ-cell tumours
- (2012) Jeffrey J.H. Low et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Chemotherapeutic Sensitivity of Testicular Germ Cell Tumors Under Hypoxic Conditions Is Negatively Regulated by SENP1-Controlled Sumoylation of OCT4
- (2012) Y.-C. Wu et al. CANCER RESEARCH
- Pro- and anti-apoptotic effects of p53 in cisplatin-treated human testicular cancer are cell context-dependent
- (2012) Alessandra di Pietro et al. CELL CYCLE
- Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary
- (2012) David M. Gershenson GYNECOLOGIC ONCOLOGY
- Transcription Factors Sp1 and p73 Control the Expression of the Proapoptotic Protein NOXA in the Response of Testicular Embryonal Carcinoma Cells to Cisplatin
- (2012) Lara Grande et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation
- (2012) Bijesh K. Biswal et al. PLoS One
- Lessons learned from testicular cancer: Identification of cytoplasmic p21 as an Achilles' heel of cisplatin resistance
- (2011) Roelof Koster et al. CELL CYCLE
- Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance
- (2011) L. H. J. Looijenga et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors
- (2011) Giorgia Mangili et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database
- (2011) Anja Lorch et al. JOURNAL OF CLINICAL ONCOLOGY
- p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin
- (2011) Matthias Gutekunst et al. PLoS One
- Disruption of the MDM2–p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway
- (2011) R Koster et al. Cell Death & Disease
- The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers
- (2010) Elodie E. Noel et al. AMERICAN JOURNAL OF PATHOLOGY
- p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors
- (2010) Baozong Li et al. CELL CYCLE
- Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
- (2010) Roelof Koster et al. JOURNAL OF CLINICAL INVESTIGATION
- TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis
- (2010) Darren R. Feldman et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance
- (2010) Hendrik Wermann et al. JOURNAL OF PATHOLOGY
- High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
- (2009) M. J. Beyrouthy et al. CANCER RESEARCH
- Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study
- (2007) K. Fizazi et al. ANNALS OF ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started